Regulatory Affairs Team

The Regulatory Affairs Team at PHAXIAM Therapeutics is responsible for navigating the complex regulatory landscape to ensure that innovative phage therapies meet all necessary compliance standards. This team collaborates closely with research and development, quality assurance, and external regulatory bodies to facilitate the approval processes for clinical trials and product commercialization, ultimately helping to bring groundbreaking treatments for resistant bacterial infections to market.